Eficácia, tolerabilidade e segurança do uso do sirolimo após o transplante renal Sirolimus efficacy, tolerability, and safety for treatment after kidney transplantation

Eficácia, tolerabilidade e segurança do uso do sirolimo após o transplante renal Sirolimus efficacy, tolerability, and safety for treatment after kidney transplantation

INTRODUÇÃO: Sirolimo (SRL) é um imunossupressor com conhecida eficácia e perfil de segurança na profilaxia da rejeição aguda após o transplante renal. OBJETIVOS: Avaliar eficácia, tolerabilidade e segurança do uso do SRL e de prednisona em associação a ciclosporina (CSA) ou tacrolimo (TAC) após o tr...

Full description

Bibliographic Details
Main Authors:	Nagilla Ione Oliveira, Kelly Miyuki Harada, Gláucio Amaral Spinelli, Sung In Park, Edison Luiz Mandia Sampaio, Cláudia Rosso Felipe, Hélio Tedesco Silva Júnior, José Osmar Medina Pestana
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Nefrologia 2009-12-01
Series:	Brazilian Journal of Nephrology
Subjects:	sirolimo tolerância medicamentosa eficácia segurança transplante de rim sirolimus drug tolerability efficacy safety renal transplantation
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002009000400004

Similar Items

DOENÇA LINFOPROLIFERATIVA PÓS-TRANSPLANTE TRATADA COM RITUXIMAB E SIROLIMUS: RELATO DE CASO E REVISÃO DA LITERATURA
by: Marcus Vinícius de Pádua Netto, et al.
Published: (2007-03-01)

Sirolimus-induced bronchiolitis obliterans organizing pneumonia in a kidney transplant recipient; a case report and review of literature
by: Behzad Einollahi, et al.
Published: (2014-07-01)

Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patients
by: Herlinda Reyes-Pérez, et al.
Published: (2016-01-01)

O contexto do transplante renal no Brasil e sua disparidade geográfica
by: José O. Medina-Pestana, et al.
Published: (2011-12-01)

Favorable Results of Concomitant Tacrolimus and Sirolimus Therapy in Taiwanese Renal Transplant Recipients at 12 Months
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01)

Lymphedema attributed to sirolimus
by: Ardalan Mohammad-Reza
Published: (2013-04-01)

Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation
by: G.A. Spinelli, et al.
Published: (2006-01-01)

Reversible sirolimus-induced pulmonary alveolar proteinosis in a renal transplant patient
by: David Eugenio Hinojosa-González, et al.
Published: (2020-01-01)

Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine
by: P.G.P. Machado, et al.
Published: (2004-09-01)

Avaliação da tolerabilidade do micofenolato sódico com revestimento entérico versus micofenolato mofetil em receptores de transplante renal
by: Alvaro Pacheco e Silva Filho, et al.
Published: (2015-09-01)

The side effect profile of sirolimus and its relationship with some variables: A retrospective study of Iranian renal transplant patients
by: Shahrzad Shahidi, et al.
Published: (2023-01-01)

Safety and effectiveness of everolimus compared with sirolimus and tacrolimus in preventing kidney transplantation rejection: a systematic review and meta-analysis
by: Morteza Arab Zozani, et al.
Published: (2015-08-01)

Autophagy in kidney transplants of sirolimus treated recipients
by: Sagar Bhayana, et al.
Published: (2017-04-01)

Sirolimus in combination with low-dose extended-release tacrolimus in kidney transplant recipients
by: Zhi-yu Zou, et al.
Published: (2023-12-01)

How We Treated a Kidney Transplant Recipient Who Was Receiving Sirolimus During the SARS-CoV-2 Pandemic? Primum Non Nocere
by: Selcuk Yaylacı, et al.
Published: (2022-06-01)

Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
by: Hee Jung Jeon, et al.
Published: (2018-08-01)

Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study
by: Rabea Asleh, et al.
Published: (2022-01-01)

Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial
by: Kwang-Woong Lee, et al.
Published: (2020-10-01)

Use of sirolimus as an adjuvant therapy for kidney transplant recipients with high-risk cutaneous squamous cell carcinomas: a prospective non-randomized controlled study
by: Marina Rezende de Fázio, et al.
Published: (2023-08-01)

De novo cancer avoidance after renal transplantation: A case–control study on low-dose sirolimus combined with a calcineurin inhibitor
by: Kuo-Hsin Chen, et al.
Published: (2015-06-01)

Terapia de indução com alentuzumabe em receptores de transplante renal Alemtuzumab induction in kidney transplant recipients
by: Edison Luiz Mandia Sampaio, et al.
Published: (2010-03-01)

Sirolimus e Prevenção Primária de Cancro Cutâneo Não-melanoma em Transplantados Renais – Um Estudo Retrospetivo
by: André Pinho, et al.
Published: (2016-08-01)

CINQUENTA ANOS DO PRIMEIRO TRANSPLANTE NO BRASIL
by: José Andrade Moura-Neto, et al.
Published: (2016-09-01)

Reduction of left ventricular hypertrophy by Sirolimus in kidney transplant recipients: a nonrandomized clinical trial
by: Sedghipour M, et al.
Published: (2012-02-01)

Sirolimus in Liver Transplant Recipients with Hepatocellular Carcinoma: An Updated Meta-Analysis
by: Zhi-Hua Zhang, et al.
Published: (2019-10-01)

Estudo Pré-Clínico de Stent com Polímero Biodegradável e Liberação Abluminal de Sirolimus
by: Celso Kiyochi Takimura, et al.
Published: (2014-06-01)

Effect of sirolimus as an immunosuppressive agent on kidney transplantation in patients with diabetes mellitus; a systematic review
by: Saeedeh Davar, et al.
Published: (2020-04-01)

Successful Treatment of Autoimmune Hemolytic Anemia with Sirolimus after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
by: Hyun Jin Park, et al.
Published: (2023-10-01)

Sirolimus may be associated with early recurrence of biliary obstruction in liver transplant patients undergoing endoscopic stenting of biliary strictures
by: James H. Tabibian, MD., et al.
Published: (2011-07-01)

Influência da manutenção hemodinâmica do doador falecido na função renal do receptor de transplante renal
by: Ana Paula Maia Baptista, et al.
Published: (2013-12-01)

Hiperparatireoidismo pós-transplante em uma unidade de transplante renal do nordeste do Brasil: prevalência e aspectos clínicos
by: David Oliveira Barbosa, et al.
Published: (2019-06-01)

De novo Renal Transplantation after Kaposi Sarcoma: Favorable Outcome in a Patient Receiving Sirolimus and Mycophenolate-Based Immunosuppression
by: F. Friedersdorff, et al.
Published: (2010-04-01)

Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations
by: Carolina Salim Gonçalves Freitas, et al.
Published: (2015-06-01)

Exploring sirolimus pharmacokinetic variability using data available from the routine clinical care of renal transplant patients: Population pharmacokinetic approach
by: Golubović Bojana, et al.
Published: (2019-01-01)

Sirolimus potentiated angioedema: A case report and review of the literature
by: Beaini Hadi, et al.
Published: (2024-01-01)

Critical analysis of graft loss and death in kidney transplant recipients treated with mTOR inhibitors
by: Luis Gustavo Modelli de Andrade, et al.

Genitourinary tuberculosis - a rare presentation of a still frequent infection in renal transplant recipients
by: Natacha Jardim Rodrigues, et al.

Aspergilose pulmonar invasiva em receptor de transplante renal - relato de caso e revisão da literatura
by: Graziela Bastos Ribas de Aguiar, et al.
Published: (2017-12-01)

Exploratory calcineurin inhibitor-free regimens in living-related kidney transplant recipients
by: R. Garcia, et al.
Published: (2007-04-01)

EXPRESSÃO DE MOLÉCULAS IMUNORREGULADORAS EM RINS NÃO-FUNCIONANTES COM REJEIÇÃO AGUDA
by: Erika Lamkowski Naka, et al.
Published: (2008-01-01)